Some Republicans are interested in attaching a repeal of the individual mandate to a tax bill, and interest from members of Congress on the impact of such a move prompted the Congressional Budget Office to publish a revised estimate of what would happen.
Although Congress has not passed legislation to wholly repeal the Affordable Care Act (ACA), there has still been interest in repealing the law in a piecemeal way. One particular way of interest has been repealing the individual mandate through the GOP’s tax bill.
Some GOP say: "can't do health care with taxes." Nonsense! Mandate is a tax! SCOTUS & Obama admin said so. IRS collects! Paid on 1040! 7/?
— Tom Cotton (@TomCottonAR) October 29, 2017
In response to interest from members of Congress, the Congressional Budget Office (CBO) and the staff of the Joint Committee on Taxation (JCT) released an updated estimate on the effects of repealing the ACA’s individual mandate, which requires people who are not eligible for exemption to either have health insurance or pay a penalty.
On Wednesday, the CBO released the newest report, which found that repealing the individual mandate would reduce the federal deficit by about $338 billion between 2018 and 2027, but during that same time period 13 million people would lose their health insurance. The report projects that healthier people would be less likely to obtain insurance, and the resulting premium increases—about 10% in most years from 2018 to 2027—would cause more people to not purchase insurance.
“In CBO and JCT’s estimation, with no penalty at all, only a small number of people who enroll in insurance because of the mandate under current law would continue to do so solely because of a willingness to comply with the law,” according to the report.
The last time the CBO estimated the effect of repealing the individual mandate, it had determined that doing so would reduce the federal deficit by more: $416 billion between 2018 and 2026. In addition, it projected that more people would lose insurance: 28 million people by 2026.
However, CBO and JCT note in the updated report that there is a lot of uncertainty surrounding the estimates they present, because of the difficulty of predicting how federal agencies, states, insurers, employers, individuals, doctors, hospitals, and other parties might respond.
“Despite the uncertainty, some effects of this policy are clear: For instance, the federal deficit would be many billions of dollars lower than under current law, and the number of uninsured people would be millions higher,” the report concluded.
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More